Accuray: New Data Reinforce Benefits of TomoTherapy® Platform for Mainstream Radiation Therapy Treatment Indications
Sunnyvale, California (ots/PRNewswire) - Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control with Reduced Toxicities Accuray Incorporated (NASDAQ: ARAY) announced today that studies continue to demonstrate the unmatched flexibility of the cutting-edge TomoTherapy® System to treat, with ...